Yahoo
Stockholm - Delayed Quote SEK

Bonesupport Holding AB (publ) (BONEX.ST)

332.60 +12.80 (+4.00%)
At close: October 23 at 5:29:37 PM GMT+2
Chart Range Bar
Loading chart for BONEX.ST
  • Previous Close 319.80
  • Open 317.00
  • Bid 330.80 x --
  • Ask 331.00 x --
  • Day's Range 311.80 - 332.60
  • 52 Week Range 165.00 - 332.60
  • Volume 942,888
  • Avg. Volume 325,592
  • Market Cap (intraday) 21.664B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 81.52
  • EPS (TTM) 4.08
  • Earnings Date Oct 22, 2026
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 368.58

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally. The company offers CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; and CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection. It also provides CERAMENT Bead Tray, an adjunctive local delivery option for surgeons desiring targeted delivery to osseous defects and for dead space management. Bonesupport Holding AB (publ) was founded in 1999 and is headquartered in Lund, Sweden.

www.bonesupport.com

143

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Performance Overview

Trailing total returns as of 10/23/2026, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

BONEX.ST
76.91%
OMX Stockholm 30 Index (^OMX)
10.15%

1-Year Return

BONEX.ST
39.51%
OMX Stockholm 30 Index (^OMX)
15.18%

3-Year Return

BONEX.ST
190.73%
OMX Stockholm 30 Index (^OMX)
53.68%

5-Year Return

BONEX.ST
772.97%
OMX Stockholm 30 Index (^OMX)
35.20%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 408.83M
Earnings 92.36M
Profit Margin 22.59%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
100M
200M
300M
400M
16.0%
18.0%
20.0%
22.0%

Analyst Insights

View More

Analyst Price Targets

280.00 Low
368.58 Average
332.60 Current
415.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    19.40%

  • Return on Assets (ttm)

    23.76%

  • Return on Equity (ttm)

    29.73%

  • Revenue (ttm)

    1.4B

  • Net Income Avi to Common (ttm)

    271.77M

  • Diluted EPS (ttm)

    4.08

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    510.52M

  • Total Debt/Equity (mrq)

    1.07%

  • Levered Free Cash Flow (ttm)

    192.1M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: